Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Molecular Ecology Resources|May 14, 2011
Using blocks of linked single nucleotide polymorphisms as highly polymorphic genetic markers for parentage analysisBeatrix Jones, Daniel Walsh, Lillian Werner, et al.The Prostate|May 12, 2018
Functional roles and potential clinical application of miRNA-345-5p in prostate cancerIlker Tinay, Mingyue Tan, Bin Gui, et al.Leukemia Research Reports|December 24, 2019
Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administrationMary Nauffal, Lillian Werner, Jian Ni, et al.Journal of Neurosurgery. Spine|December 3, 2010
Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical articleDan Michael Drzymalski, William K Oh, Lillian Werner, et al.British Journal of Haematology|June 3, 2015
Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohortMatthew S Davids, Alexander Vartanov, Lillian Werner, et al.Clinical Genitourinary Cancer|October 1, 2011
Secondary hormonal therapy in men with castration-resistant prostate cancerMari Nakabayashi, Lillian Werner, William K Oh, et al.Plos One|May 30, 2015
Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostateJean-Christophe Pignon, Chiara Grisanzio, Ingrid Carvo, et al.The Journal of Urology|December 21, 2010
Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillanceIgnacio F San Francisco, Lillian Werner, Meredith M Regan, et al.Scientific Reports|June 11, 2016
Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial CarcinomaStephanie A Mullane, Lillian Werner, Jonathan Rosenberg, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 10, 2010
Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapyTong Sun, Gwo-Shu Mary Lee, Lillian Werner, et al.Pageof 8